New drug tested to tame dangerous blood fats
NCT ID NCT03783377
Summary
This early-stage study tested a new drug called ARO-APOC3 to see if it is safe for people. It involved 112 healthy adults and patients with very high levels of blood fats (triglycerides), including a rare genetic condition. The main goal was to check for side effects and see how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 10
Papatoetoe, Auckland, 2025, New Zealand
-
Research Site 11
Christchurch, 8011, New Zealand
-
Research Site 2
Camperdown, New South Wales, 2050, Australia
-
Research Site 3
Adelaide, South Australia, 5000, Australia
-
Research Site 4
Perth, Washington, 6009, Australia
-
Research Site 5
Sippy Downs, Queensland, Australia
-
Research Site 6
Chicoutimi, Quebec, G7H 7K9, Canada
-
Research Site 7
London, Ontario, N6A 5B7, Canada
-
Research Site 8
Montreal, Quebec, H2W 1R7, Canada
-
Research Site 9
Grafton, Auckland, 1010, New Zealand
Conditions
Explore the condition pages connected to this study.